Learn about CVE-2017-12712 affecting Abbott Laboratories pacemakers manufactured before Aug 28, 2017. Find out the impact, affected systems, and mitigation steps.
Abbott Laboratories pacemakers manufactured before August 28, 2017 are vulnerable to an authentication algorithm issue that could allow unauthorized commands via RF communications.
Understanding CVE-2017-12712
This CVE involves a vulnerability in the authentication algorithm of specific Abbott Laboratories pacemakers.
What is CVE-2017-12712?
The vulnerability lies in the authentication algorithm of Abbott Laboratories pacemakers manufactured before August 28, 2017. This flaw could be exploited by an attacker in close proximity to issue unauthorized commands to the pacemaker using RF communications.
The Impact of CVE-2017-12712
The severity of this vulnerability is rated with a CVSS v3 base score of 7.5, indicating high impact potential on confidentiality, integrity, and availability of affected devices.
Technical Details of CVE-2017-12712
This section provides detailed technical information about the CVE.
Vulnerability Description
The vulnerability stems from an authentication algorithm flaw in Abbott Laboratories pacemakers, allowing unauthorized commands via RF communications.
Affected Systems and Versions
Exploitation Mechanism
The vulnerability can be exploited by compromising or bypassing the authentication process, enabling attackers in close proximity to issue unauthorized commands using RF communications.
Mitigation and Prevention
Protecting systems from CVE-2017-12712 is crucial to prevent unauthorized access and potential harm.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates